New York Post · General

Swiss dental startup vVardis shares slide 7% in NYSE debut as tech selloff roils IPO market

· By Reuters
Story summary

vVardis had sold 9.7 million shares at $18 apiece in its IPO, well below its targeted range of $21 to $24 per share.

Read at New York Post

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.

Your local edition.

Choose a timezone for story timestamps and date filters.